Aprea Therapeutics completes 1-for-20 reverse stock split; Nasdaq halt through Feb 14

Aprea Therapeutics, Inc.

Reverse stock split 1-for-20 effective 5:00 p.m. ET on Feb 10, 2023.
Nasdaq halted trading in APRE at 7:50 p.m. Feb 10 pending material news related to split.
Halt is administrative; trading expected to resume at 9:45 a.m. on Feb 14, 2023.

item 8.01 item 9.01

Aprea Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-019906

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.